jueves, 1 de enero de 2026

APOEε4 and Alzheimer's treatment

https://www.news-medical.net/whitepaper/20251210/APOEceb54-and-Alzheimers-treatment.aspx Since the identification of Apolipoprotein E (APOE) ε4 as the strongest genetic risk factor for Alzheimer's Disease (AD), it has served as a critical marker for predicting disease susceptibility.

No hay comentarios:

Publicar un comentario